Ophthalmic light sensitive nanocarrier systems. - Wikidata - wikimedia - TriplyDB

Ophthalmic light sensitive nanocarrier systems.

Ophthalmic light sensitive nanocarrier systems.

http://www.wikidata.org/entity/Q37085078

about

Intraocular Implants for the Treatment of Autoimmune Uveitis Targeted cytosolic delivery of cell-impermeable compounds by nanoparticle-mediated, light-triggered endosome disruption.Novel dual-control poly(N-isopropylacrylamide-co-chlorophyllin) nanogels for improving drug release.Shining light on nanotechnology to help repair and regeneration.Toxicity of therapeutic nanoparticles.Nanomedicines for back of the eye drug delivery, gene delivery, and imaging.Porphyrin-loaded nanoparticles for cancer theranostics.Light-responsive in situ forming injectable implants for effective drug delivery to the posterior segment of the eye.Mechanoresponsive materials for drug delivery: Harnessing forces for controlled release.Nanocrystal for ocular drug delivery: hope or hype.Light-activated, in situ forming gel for sustained suprachoroidal delivery of bevacizumab.Photo-Modulated Therapeutic Protein Release from a Hydrogel Depot Using Visible Light.How are we improving the delivery to back of the eye? Advances and challenges of novel therapeutic approaches.Ocular Drug Delivery.

P2860

Q26799168-63F89261-94D5-4912-BBA6-18E5AE5EEEA8 Q30580747-6F3CEFC0-5028-4FC7-B784-F5D7E43FBA6F Q34183165-FF3910D5-DBE1-4CBA-8464-FA06A3492CA6 Q34404413-2AA7AFCA-0511-4119-A363-F415324EFAA9 Q37385444-41D52927-9179-41F5-A696-9623F7672683 Q38100561-DFDA0ACF-92BF-4233-A850-B849180D21E2 Q38686870-9B4001EC-2875-4485-8EC5-4228E7906355 Q38769853-6A9C600A-F506-4196-BAF3-49591DF99822 Q38794346-00D862B3-8BA1-4886-93A6-34D1A1D63CD6 Q38831205-4A39FA6D-4903-4F48-8ACB-6E1B42D9334F Q39038492-9AD19C90-01BC-4799-9283-AC36447B1997 Q48180462-2445ED2C-DCE4-4999-ABA9-FBA7FE64B1A5 Q48902538-8E92621A-323F-4783-9603-64468CFDDFD5 Q51122641-CC0D5D79-8121-42C5-9562-495A70A7B782

P2860

Ophthalmic light sensitive nanocarrier systems.

http://www.wikidata.org/entity/Q37085078

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Ophthalmic light sensitive nanocarrier systems.

@en

Ophthalmic light sensitive nanocarrier systems.

@nl

type

label

Ophthalmic light sensitive nanocarrier systems.

@en

Ophthalmic light sensitive nanocarrier systems.

@nl

prefLabel

Ophthalmic light sensitive nanocarrier systems.

@en

Ophthalmic light sensitive nanocarrier systems.

@nl

P1433

Q37085078-EB4D78A6-E5A6-492D-AFF8-363C434796CC

P1476

Q37085078-0F35DCB4-D2D4-4EEB-9C5F-753F056FBF56

P2093

Q37085078-A164E192-B98C-4AA5-863A-D537AC3D1588

Q37085078-E600934B-0277-4D14-9507-3E24D508BE3E

P2860

Q37085078-001A5F69-D36D-4277-8AA0-76DD799E4AD5

Q37085078-07031BDA-8A85-430B-AF04-9E523F69D3A9

Q37085078-0A552BF1-A9FF-4ADF-A1E8-3760D6B0471E

Q37085078-0B391A75-8AEA-4385-ADD0-1C2F7B207F60

Q37085078-16E4A46F-B5B0-4ECC-89D4-C0A62DB2C1DE

Q37085078-16E8514C-30E9-41A2-A2FD-FA985CFE3189

Q37085078-17114719-53C0-4F58-BBC8-263172504244

Q37085078-17E0B7F2-6A95-4E9C-B3C8-6670F6182243

Q37085078-1E9DE5EB-61AB-4433-84EC-46AB2BAA8D78

Q37085078-1FEF05DF-274D-490C-B3EC-0B5CB20D095D

P304

Q37085078-A36D5893-2438-449C-8D08-2B655BA4A6A5

P31

Q37085078-3AF68696-207D-459E-9E23-27454E476236

P356

Q37085078-C0A4F81C-365D-43AB-91C0-A135D516C958

P433

Q37085078-6AF68E24-B621-4A43-9110-A609DDD8D75F

P478

Q37085078-3156F775-6D57-4DB3-BD0C-CEE744104DC2

P577

Q37085078-AA0AE014-4916-417E-9A93-BB270F2745A7

P5875

Q37085078-D6C3022B-DBF0-40D0-B887-3230B05BB5A7

P698

Q37085078-3DA42798-DC50-4A4B-A5E9-C074A58FF28C

P921

Q37085078-B1E57C9E-4ABC-4A5D-BF85-0135B758A0CA

P932

Q37085078-03E7F470-21AD-47B6-BA4A-A2CA2E5E13F5

P356

J.DRUDIS.2007.12.005

P1433

Drug Discovery Today

P1476

Ophthalmic light sensitive nanocarrier systems.

@en

P2093

Jennifer G Christie

http://www.w3.org/2001/XMLSchema#string

Uday B Kompella

http://www.w3.org/2001/XMLSchema#string

P2860

Light-induced gene transfer from packaged DNA enveloped in a dendrimeric photosensitizer.

Photoinduced destabilization of liposomes.

VP22 light controlled delivery of oligonucleotides to ocular cells in vitro and in vivo.

Gene therapy in the cornea.

Argon laser photodynamic therapy of human corneal neovascularization after intravenous administration of dihematoporphyrin ether.

Type I and type II photosensitization by the antibacterial drug nalidixic acid. A laser flash photolysis study.

Art and science of photodynamic therapy.

Specific regulation of gene expression by antisense, sense and antigene nucleic acids.

Synergies of VEGF inhibition and photodynamic therapy in the treatment of age-related macular degeneration.

AQ4, an antitumor anthracenedione, inhibits endothelial cell proliferation and vascular endothelial growth factor secretion: implications for the therapy of ocular neovascular disorders.

P304

124-134

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.DRUDIS.2007.12.005

http://www.w3.org/2001/XMLSchema#string

P433

3-4

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2008-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5575928

http://www.w3.org/2001/XMLSchema#string

P698

18275910

http://www.w3.org/2001/XMLSchema#string

P921

P932

2274995

http://www.w3.org/2001/XMLSchema#string